X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2457) 2457
drug combinations (2431) 2431
male (1845) 1845
antineoplastic combined chemotherapy protocols - therapeutic use (1679) 1679
tegafur - administration & dosage (1624) 1624
oxonic acid - administration & dosage (1623) 1623
aged (1587) 1587
female (1502) 1502
middle aged (1495) 1495
oxonic acid - therapeutic use (1139) 1139
tegafur - therapeutic use (1136) 1136
stomach neoplasms - drug therapy (1124) 1124
oncology (894) 894
stomach neoplasms - pathology (894) 894
index medicus (870) 870
adult (806) 806
s-1 (744) 744
cisplatin - administration & dosage (674) 674
chemotherapy (652) 652
antimetabolites, antineoplastic - therapeutic use (602) 602
treatment outcome (602) 602
cancer (561) 561
stomach neoplasms - surgery (537) 537
neoplasm staging (528) 528
oxonic acid - adverse effects (497) 497
tegafur - adverse effects (493) 493
drug administration schedule (481) 481
antineoplastic combined chemotherapy protocols - adverse effects (417) 417
aged, 80 and over (411) 411
adenocarcinoma - drug therapy (375) 375
combined modality therapy (368) 368
5-fluorouracil (364) 364
gastrectomy (360) 360
medicine & public health (337) 337
survival rate (327) 327
cisplatin (323) 323
deoxycytidine - analogs & derivatives (322) 322
gastric cancer (310) 310
tomography, x-ray computed (305) 305
lymphatic metastasis (302) 302
antimetabolites, antineoplastic - administration & dosage (298) 298
pyridines - administration & dosage (286) 286
chemotherapy, adjuvant (281) 281
stomach cancer (280) 280
liver neoplasms - secondary (276) 276
administration, oral (274) 274
camptothecin - analogs & derivatives (273) 273
fluorouracil (273) 273
disease-free survival (272) 272
care and treatment (248) 248
pharmacology & pharmacy (247) 247
trial (246) 246
prognosis (239) 239
liver neoplasms - drug therapy (236) 236
camptothecin - administration & dosage (232) 232
cancer research (219) 219
surgery (219) 219
neoadjuvant therapy (218) 218
deoxycytidine - administration & dosage (217) 217
carcinoma (216) 216
retrospective studies (216) 216
taxoids - administration & dosage (212) 212
lung neoplasms - drug therapy (199) 199
pancreatic neoplasms - drug therapy (195) 195
paclitaxel - administration & dosage (194) 194
stomach neoplasms - mortality (191) 191
therapy (191) 191
fluorouracil - administration & dosage (187) 187
research (186) 186
remission induction (183) 183
surgical oncology (181) 181
capecitabine (176) 176
survival (174) 174
antineoplastic combined chemotherapy protocols - administration & dosage (169) 169
peritoneal neoplasms - secondary (168) 168
adenocarcinoma - pathology (167) 167
metastasis (167) 167
antimetabolites, antineoplastic - adverse effects (166) 166
phase-ii (166) 166
time factors (165) 165
organoplatinum compounds - administration & dosage (164) 164
pyridines - therapeutic use (163) 163
antineoplastic agents (161) 161
pancreatic neoplasms - pathology (161) 161
antimitotic agents (159) 159
oxaliplatin (158) 158
animals (157) 157
follow-up studies (156) 156
adenocarcinoma - secondary (155) 155
cisplatin - therapeutic use (154) 154
clinical trials (153) 153
radiotherapy (153) 153
analysis (152) 152
adenocarcinoma (143) 143
adjuvant chemotherapy (143) 143
adenocarcinoma - surgery (142) 142
gemcitabine (142) 142
docetaxel (141) 141
oncology, experimental (139) 139
gastroenterology & hepatology (138) 138
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1279) 1279
Japanese (1237) 1237
Chinese (15) 15
French (4) 4
Czech (1) 1
German (1) 1
Italian (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 01/2015, Volume 26, Issue 1, pp. 141 - 148
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 3, pp. 215 - 221
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 11, pp. 1063 - 1069
Summary Background The best chemotherapy regimen for metastatic gastric cancer is uncertain, but promising findings have been reported with irinotecan plus... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | 5-FLUOROURACIL | ONCOLOGY | HIGH-DOSE METHOTREXATE | DOXORUBICIN | ADVANCED ESOPHAGOGASTRIC CANCER | COOPERATIVE GROUP | EUROPEAN-ORGANIZATION | 1ST-LINE THERAPY | III TRIAL | CHEMOTHERAPY | Japan - epidemiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - secondary | Cisplatin - administration & dosage | Young Adult | Fluorouracil - therapeutic use | Fluorouracil - adverse effects | Time Factors | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Drug Administration Schedule | Risk Assessment | Administration, Oral | Tegafur - adverse effects | Tegafur - therapeutic use | Proportional Hazards Models | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Infusions, Intravenous | Stomach Neoplasms - mortality | Drug Combinations | Adenocarcinoma - mortality | Chemotherapy | Oncology, Experimental | Information services | Research | Metastasis | Stomach cancer | Information services industry | Cancer | Fluorouracil | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 18, pp. 1810 - 1820
Journal Article
Annals of Oncology, ISSN 0923-7534, 2014, Volume 25, Issue 9, pp. 1743 - 1749
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 90 - 98
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2013, Volume 24, Issue 5, pp. 1326 - 1331
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2011, Volume 68, Issue 1, pp. 157 - 164
Curcumin, a plant-derived natural polyphenol, could be a promising anti-cancer drug and shows synergic effects with cytotoxic agents. We evaluated the safety... 
Medicine & Public Health | Gemcitabine | Pancreatic cancer | Oncology | Cancer Research | Curcumin | Pharmacology/Toxicology | APOPTOSIS | ACTIVATION | CELL-PROLIFERATION | SUPPRESSION | I CLINICAL-TRIAL | 5-FLUOROURACIL | THERAPY | INHIBITION | ONCOLOGY | GENE-PRODUCTS | PHARMACOLOGY & PHARMACY | EXPRESSION | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - administration & dosage | Curcumin - administration & dosage | Pancreatic Neoplasms - drug therapy | Adenocarcinoma - physiopathology | Antineoplastic Agents - adverse effects | Deoxycytidine - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Pancreatic Neoplasms - mortality | Deoxycytidine - administration & dosage | Tegafur - adverse effects | Tegafur - therapeutic use | Curcumin - pharmacokinetics | Survival Rate | Curcumin - adverse effects | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Drug Synergism | Medication Adherence | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents - blood | Aged | Pancreatic Neoplasms - physiopathology | Deoxycytidine - analogs & derivatives | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Care and treatment | Cancer patients | Chemotherapy | Gastrointestinal agents | Oncology, Experimental | Research | Cancer | Index Medicus
Journal Article
Gastric Cancer, ISSN 1436-3291, 3/2011, Volume 14, Issue 1, pp. 72 - 80
Irinotecan hydrochloride and S-1, an oral fluoropyrimidine, have shown antitumor activity against advanced gastric cancer as single agents in phase I/II... 
Pathology | Phase III | Irinotecan S-1 | Medicine & Public Health | Gastroenterology | Oncology | Radiotherapy | Surgical Oncology | Gastric cancer | Randomized controlled trial | CPT-11 | ADENOCARCINOMA | FOLINIC ACID | COMBINATION | FLUOROURACIL | DOCETAXEL | CHEMOTHERAPY | TRIAL | 5-FLUOROURACIL | CISPLATIN | ONCOLOGY | GASTROENTEROLOGY & HEPATOLOGY | Follow-Up Studies | Humans | Middle Aged | Male | Antimetabolites, Antineoplastic - administration & dosage | Young Adult | Antineoplastic Agents, Phytogenic - administration & dosage | Adult | Camptothecin - administration & dosage | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Antineoplastic Agents, Phytogenic - adverse effects | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Tegafur - adverse effects | Tegafur - therapeutic use | Neoplasm Recurrence, Local | Antineoplastic Combined Chemotherapy Protocols | Treatment Outcome | Oxonic Acid - administration & dosage | Stomach Neoplasms - drug therapy | Disease Progression | Oxonic Acid - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Tegafur - administration & dosage | Aged | Drug Combinations | Medical colleges | Care and treatment | Oncology, Experimental | Diarrhea | Research | Drug therapy | Stomach cancer | Cancer | Original
Journal Article
Journal Article
Journal Article
Journal Article